Alemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic LeukemiaPeter Hillmen, Jiřı́ Mayer, Jingyang Wu et al.|Journal of Clinical Oncology|2007Cited by 556
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)David R. Wise, Kwok‐Kin Wong, Samuel R. Denmeade et al.|Prostate Cancer and Prostatic Diseases|2024Cited by 9